Clinical Trial Update: Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing chemotherapy plus hormone therapy versus androgen suppression in metastatic or unresectable prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED